Holen Sie sich die Stockscreener-App
38.16
0.57%
-0.22
Handel nachbörslich:
38.50
0.34
+0.89%
Astrana Health Inc Aktie (ASTH) Neueste Nachrichten
Is Astrana Health Inc (ASTH) a Bargain After 3.1% Drop? GF Value Says Undervalued - GuruFocus
Astrana Health (ASTH) director receives 4,525 restricted stock award - Stock Titan
Director Mazdyasni granted 4,525 Astrana Health (ASTH) restricted shares vesting in 2027 - Stock Titan
Astrana Health (ASTH) director gets 4,991 new restricted shares - Stock Titan
Astrana Health (ASTH) director Weili Dai receives 4,525-share restricted stock grant - Stock Titan
[Form 4] Astrana Health, Inc. Insider Trading Activity - Stock Titan
Astrana Health stock hits 52-week high at 39.97 USD By Investing.com - Investing.com Nigeria
ASTH Stock Price, Quote & Chart - ChartMill
Astrana Health stock hits 52-week high at 39.97 USD - Investing.com
ASTH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Astrana Health (ASTH) investors approve expanded 2024 equity incentive plan to 2036 - Stock Titan
Will First-Time Fortune 1000 Status Reshape Astrana Health's (ASTH) Value-Based Care Investment Narrative? - simplywall.st
Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth - PR Newswire
AI-driven Astrana Health hits $3.18B revenue, now a Fortune 1000 company - Stock Titan
ASTH Reiterated by BTIG -- Price Target Maintained at $50.00 - GuruFocus
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Astrana Health (ASTH) price target increased by 18.07% to 44.43 - MSN
Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates - MSN
Astrana Health names George Christides interim medical director By Investing.com - Investing.com Nigeria
Astrana Health Raised to Overweight From Equal-Weight by Barclays - Moomoo
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack - Yahoo Finance
Astrana Health Q1 2026 slides: 56% revenue growth, full-risk shift accelerates - Investing.com Nigeria
Astrana Health closes deal with Prospect Health at a lower price - MSN
Does Astrana’s AI Partnership With California Physicians Reshape the Bull Case for Astrana Health (ASTH)? - Sahm
A Look at Astrana Health Inc (ASTH) After 3.5% Decline -- GF Val - GuruFocus
Cash-Rich Stocks: Appian and Array Face Challenges, Astrana Health ShinesNews and Statistics - IndexBox
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)? - Yahoo Finance
52-Week High Stocks: Sell EchoStar, Watch Vita Coco and Astrana HealthNews and Statistics - IndexBox
Astrana Health (ASTH) COO and CFO surrenders 8,155 shares for tax withholding - Stock Titan
Astrana Health partners with California physician group By Investing.com - Investing.com Nigeria
Astrana Health says Prospect deal is ahead of schedule as Q1 trends beat expectations - MSN
Astrana Health Q1 2026 Results: Revenue Beat and AI-Driven Growth - IndexBox
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call - Yahoo Finance
Will Strong Q1 Results and New Leadership Shift Astrana Health's (ASTH) Value-Based Care Narrative - simplywall.st
Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Bristol-Myers Squibb (BMY) and Progyny (PGNY) - The Globe and Mail
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $47 - Moomoo
Truist raises Astrana Health stock price target to $47 on outlook - Investing.com UK
Truist raises Astrana Health stock price target to $47 on outlook By Investing.com - Investing.com South Africa
BofA Securities Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
Astrana Health Updates Investor Presentation via Regulation FD Disclosure - The Globe and Mail
0.28%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):